| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| review article | Q7318358 |
| P50 | author | Ahmed El-Badawy | Q56014830 |
| P2093 | author name string | Nagwa El-Badri | |
| P2860 | cites work | Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells | Q21245299 |
| The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | Q27860509 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses | Q27860840 | ||
| Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 | ||
| C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus | Q28241260 | ||
| Improvement in outcomes of clinical islet transplantation: 1999-2010. | Q30418470 | ||
| A preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus. | Q33746422 | ||
| Acute response of peripheral blood cell to autologous hematopoietic stem cell transplantation in type 1 diabetic patient | Q34182038 | ||
| Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group | Q34800286 | ||
| Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial | Q35321191 | ||
| Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptide | Q35563587 | ||
| Mesenchymal stem cells for the treatment of diabetes | Q35976665 | ||
| Diabetic ketoacidosis at diagnosis influences complete remission after treatment with hematopoietic stem cell transplantation in adolescents with type 1 diabetes | Q36047307 | ||
| Update on islet transplantation | Q36065843 | ||
| Cochrane Collaboration: more than systematic reviews? | Q50779792 | ||
| Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus. | Q51034470 | ||
| Preserved β-cell function in type 1 diabetes by mesenchymal stromal cells. | Q51055565 | ||
| Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis. | Q51073532 | ||
| Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. | Q51348903 | ||
| Autologous hematopoietic stem cell transplantation modulates immunocompetent cells and improves β-cell function in Chinese patients with new onset of type 1 diabetes. | Q51359614 | ||
| Meta-analysis in the design and monitoring of clinical trials. | Q52303075 | ||
| Lessons learned from the international trial of the edmonton protocol for islet transplantation. | Q53231319 | ||
| International trial of the Edmonton protocol for islet transplantation. | Q54032399 | ||
| Autologous bone marrow mononuclear cell infusion and hyperbaric oxygen therapy in type 2 diabetes mellitus: an open-label, randomized controlled clinical trial. | Q54512489 | ||
| The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF | Q56986459 | ||
| Co-publishing Cochrane Library systematic reviews: journal editor and Cochrane Skin Group author experiences | Q57243672 | ||
| Efficacy and Safety of Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients with Type 2 Diabetes Mellitus: A Randomized Placebo-Controlled Study | Q58634190 | ||
| Diabetes in numbers | Q59060244 | ||
| Cardiovascular disease and neoplasms after pancreas transplantation | Q77506828 | ||
| Intrapancreatic delivery of human umbilical cord blood aldehyde dehydrogenase-producing cells promotes islet regeneration | Q83705789 | ||
| Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I | Q84485378 | ||
| Diabetes impairs stem cell and proangiogenic cell mobilization in humans | Q36720330 | ||
| Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin | Q37191602 | ||
| Early immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: preliminary results | Q37255164 | ||
| The clinical impact of islet transplantation | Q37283965 | ||
| Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with Type 1 diabetes. | Q37367372 | ||
| Autologous umbilical cord blood transfusion in very young children with type 1 diabetes | Q37400863 | ||
| Islet transplantation stabilizes hemostatic abnormalities and cerebral metabolism in individuals with type 1 diabetes. | Q37403188 | ||
| Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for insulin-dependent diabetes mellitus | Q37825434 | ||
| Pancreatic islet cell transplantation: an update for interventional radiologists | Q37993667 | ||
| Effects of donor-, pancreas-, and isolation-related variables on human islet isolation outcome: a systematic review. | Q38103329 | ||
| Mesenchymal stem cell therapy in diabetes mellitus: progress and challenges | Q38114073 | ||
| Regulators of pluripotency and their implications in regenerative medicine | Q38471080 | ||
| Effect of a single autologous cord blood infusion on beta-cell and immune function in children with new onset type 1 diabetes: a non-randomized, controlled trial | Q39337595 | ||
| Arterial supply to the pancreas; variations and cross-sectional anatomy | Q39901634 | ||
| Demonstration of the dorsal pancreatic artery by CTA to facilitate superselective arterial infusion of stem cells into the pancreas. | Q39970712 | ||
| Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study | Q40321403 | ||
| Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1. | Q41964589 | ||
| Pancreas transplantation in the United States: an analysis of the UNOS registry. | Q43043380 | ||
| Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus | Q43290819 | ||
| Long term effects of the implantation of autologous bone marrow mononuclear cells for type 2 diabetes mellitus | Q43491599 | ||
| The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. | Q43599448 | ||
| Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations | Q44133679 | ||
| Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation | Q44198535 | ||
| Improved insulin secretion following intrapancreatic UCB transplantation in patients with T2DM. | Q45760155 | ||
| Addition of plerixafor for CD34+ cell mobilization in six healthy stem cell donors ensured satisfactory grafts for transplantation | Q47780526 | ||
| Combined insulin and bicarbonate therapy elicits cerebral edema in a juvenile mouse model of diabetic ketoacidosis | Q48266535 | ||
| Impact of islet transplantation on diabetes complications and quality of life | Q48631653 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type-1 diabetes | Q124407 |
| meta-analysis | Q815382 | ||
| type 2 diabetes | Q3025883 | ||
| stem cell transplantation | Q65592366 | ||
| cell- and tissue-based therapy | Q65593162 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e0151938 | |
| P577 | publication date | 2016-04-13 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-Analysis | |
| P478 | volume | 11 |
| Q30829638 | Adipose Stem Cells Display Higher Regenerative Capacities and More Adaptable Electro-Kinetic Properties Compared to Bone Marrow-Derived Mesenchymal Stromal Cells. |
| Q54210026 | Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study. |
| Q41714358 | Advances in paediatrics in 2016: current practices and challenges in allergy, autoimmune diseases, cardiology, endocrinology, gastroenterology, infectious diseases, neonatology, nephrology, neurology, nutrition, pulmonology |
| Q47130831 | Cancer cell-soluble factors reprogram mesenchymal stromal cells to slow cycling, chemoresistant cells with a more stem-like state. |
| Q90049975 | Considerations on the harvesting site and donor derivation for mesenchymal stem cells-based strategies for diabetes |
| Q64282542 | Efficacy of Autologous Bone Marrow Mononuclear Cell Transplantation Therapy for Type 2 Diabetes Mellitus: An Updated Meta-Analysis |
| Q89497850 | Evaluation of the Consistency and Composition of Commercially Available Bone Marrow Aspirate Concentrate Systems |
| Q89450170 | Improved therapeutics of modified mesenchymal stem cells: an update |
| Q33691629 | Mesenchymal stem cell therapy in type 2 diabetes mellitus |
| Q52676718 | Mesenchymal stem cells in the treatment of Cesarean section skin scars: study protocol for a randomized, controlled trial. |
| Q47157807 | Microvascular Complications in Type 1 Diabetes: A Comparative Analysis of Patients Treated with Autologous Nonmyeloablative Hematopoietic Stem-Cell Transplantation and Conventional Medical Therapy |
| Q52724490 | Quality-Quantity Control Culture Enhances Vasculogenesis and Wound Healing Efficacy of Human Diabetic Peripheral Blood CD34+ Cells. |
| Q48158567 | Safety and efficacy of hematopoietic and mesanchymal stem cell therapy for treatment of T1DM: a systematic review and meta-analysis protocol |
| Q98291518 | The "Salmon Spirit" of translational medical research |
| Q89496687 | The Clinical Efficacy and Safety of Stem Cell Therapy for Diabetes Mellitus: A Systematic Review and Meta-Analysis |
| Q48192410 | The features of adipose-derived stem cells in patients with inflammatory bowel diseases. |
| Q89737509 | Therapeutic Potential of Wharton's Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges |
| Q39455373 | Therapeutic potential of mesenchymal stem cells for diabetes |
Search more.